# Australian Nuclear Science and Technology Organization

> Australian Nuclear Science and Technology Organization is a VC fund backing Health Care. See 1 investment, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Clayton, Australia
- Total investments: 1
- Last investment: May 2016
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ansto
- X (Twitter): https://www.twitter.com/ansto
- Website: http://www.ansto.gov.au/
- Facebook: https://www.facebook.com/discoveransto

Australian Nuclear Science and Technology Organization is a VC fund in Clayton focused on Health Care and Biotechnology. Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Clarity Pharmaceuticals | Clarity is a personalized medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally.Clarity’s platform technology allows antibodies to be radiolabeledand visualized using PET imaging. The human imaging data generated provides information on whether the drug reaches the desired disease target in a patient. This information enables a personalized approach to therapy by only treating those patients that are likely to respond to therapy and excluding those that won’t respond to therapy. This precision medicine approach is at the forefront of drug development. | $2M |  | May 24, 2016 | http://www.claritypharmaceuticals.com/ |

1 of 1 investments shown.

## Co-investors
- [Cicada Innovations](https://shizune.co/investors/profile/atp-innovations) — VC Fund, 1 deal together
- [ATP Innovations](https://shizune.co/investors/profile/atp-innovations-4ed9) — VC Fund, 1 deal together
- [University of Melbourne](https://shizune.co/investors/profile/the-university-of-melbourne) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Biotech Investors in Australia](https://shizune.co/investors/biotech-investors-australia)
- [Biotech VC Funds in Australia](https://shizune.co/investors/biotech-vc-funds-australia)
- [Biotechnology Investors in Australia](https://shizune.co/investors/biotechnology-investors-australia)
- [Biotechnology VC Funds in Australia](https://shizune.co/investors/biotechnology-vc-funds-australia)
- [Biotech VC Funds in Oceania](https://shizune.co/investors/biotech-vc-funds-oceania)

## FAQ

### What does Australian Nuclear Science and Technology Organization invest in?

Australian Nuclear Science and Technology Organization invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Australian Nuclear Science and Technology Organization last invest?

The most recent investment recorded for Australian Nuclear Science and Technology Organization closed in May 2016. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
